Question 1

Does Royal Bank of Canada own NTLA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Royal Bank of Canada holds 673,340 shares of NTLA (Intellia Therapeutics), worth $11.4M.

Question 2

How many shares of NTLA does Royal Bank of Canada own?

Accepted Answer

As of its Q2 2026 13F, Royal Bank of Canada holds 673,340 shares of NTLA (Intellia Therapeutics).

Question 3

What is Royal Bank of Canada's NTLA position worth?

Accepted Answer

As of its Q2 2026 13F, Royal Bank of Canada's NTLA position is worth $11.4M.

Question 4

Is Royal Bank of Canada buying or selling NTLA?

Accepted Answer

In Q2 2026, Royal Bank of Canada increased its NTLA position by 207,841 shares (+44.7%).

Question 5

When did Royal Bank of Canada first buy NTLA?

Accepted Answer

Royal Bank of Canada already held NTLA in its Q3 2019 13F, the earliest on record, and has listed it in 28 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	673,340	+44.6%	$11.4M	0.0%	$16.92	38
2026-Q1	Increased	465,499	+1082.1%	$6M	0.0%	$12.82	44
2025-Q4	Decreased	39,378	-91.5%	$355,000	0.0%	$8.99	0
2025-Q3	Decreased	464,527	-8.0%	$8M	0.0%	$17.27	0
2025-Q2	Increased	504,774	+1643.8%	$4.7M	0.0%	$9.38	43
2025-Q1	Decreased	28,946	-23.1%	$206,000	0.0%	$7.11	0
2024-Q4	Decreased	37,644	-67.0%	$439,000	0.0%	$11.66	0
2024-Q3	Decreased	114,134	-0.5%	$2.3M	0.0%	$20.55	0